Experience

Bioverativ, a Sanofi company

• United States
• Biotechnology
• 1 - 100 Employee

• Principal Associate Scientist

  • Jan 2019 - Present

  Rare Blood Disorders Research Group Rare Blood Disorders Research Group



Bioverativ

• Waltham, MA

• Principal Associate Scientist

  • Jan 2017 - Jan 2019

  Gene Therapy Research Gene Therapy Research



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Principal Associate Scientist

  • May 2015 - Jan 2017

  Cell and Gene Therapy Group

• Senior Associate Scientist

  • Mar 2012 - May 2015

  Hematology Group

• Associate Scientist III

  • Oct 2010 - Mar 2012



Avigen

• Biotechnology Research
• 1 - 100 Employee

• Research Contractor/Consultant

  • Nov 2005 - Nov 2008

  -Part-time Research Associate (varying from 15-30 hours per week) -Researching a small molecule candidate for hemophilia -Bench and animal work -Part-time Research Associate (varying from 15-30 hours per week) -Researching a small molecule candidate for hemophilia -Bench and animal work



Avigen

• Biotechnology Research
• 1 - 100 Employee

• Research Associate II - IV

  • Jul 1999 - Jul 2005

  -Played a key role in defining the efficacy of adeno-associated virus (AAV) -mediated gene therapy for hemophilia A and B -Examined expression levels, transduction efficiency, and immunological effects of various AAV-Factor VIII & IX vectors (various AAV serotypes and expression cassettes) in tissue culture, in hemophiliac mice and dogs, and in non-human primates -Produced, purified, and characterized AAV-Factor VIII vectors -Independently designed efficacy studies in mice and supervised an associate during mouse surgeries and plasma collection -Performed animal husbandry of normal and immunocompromised mouse lines -Analyze data using graphing and statistics programs and provide study summaries for supervisors -Routinely present research results at group meetings and presented a poster at the American Society for Gene Therapy Meeting -Cloned various AAV constructs for neuropathic pain studies in house Show less



Gladstone Institute of Cardiovascular Disease

• Research Associate I

  • Jul 1997 - Jun 1999

  -Determined the secondary structure of the ApoB mRNA responsible for protein-RNA interaction -Characterized the effects of tissue-specific overexpression of the apobec-1 enzyme in mice using the Tet-op transgenic system -Co-managed a tissue culture facility. Maintained inventory, trained personnel, and serviced equipment -Performed animal husbandry and maintained 10 transgenic mouse lines -Determined the secondary structure of the ApoB mRNA responsible for protein-RNA interaction -Characterized the effects of tissue-specific overexpression of the apobec-1 enzyme in mice using the Tet-op transgenic system -Co-managed a tissue culture facility. Maintained inventory, trained personnel, and serviced equipment -Performed animal husbandry and maintained 10 transgenic mouse lines